Episode 83 – RLR – Lymphadenopathy

Episode 83 – RLR – Lymphadenopathy

Up next

Episode 440: Subspecialty Episode – Pelvic & Joint Pain

Greg and Jeffrey discuss an interesting case at the intersection of rheumatology, neurology, and pelvic medicine. To join us live on Virtual Morning Report (VMR), sign up HERE. Download CPSolvers App here RLRCPSOLVERS 

Episode 439 – Spaced Learning Series – SOB

Episode description: An episode that left us catching our breath. Tune in for a journey of twists and turns with us! Featuring: Valeria RoldanJasdeep BajwaMukund Raguram SchemasDyspnea pyramidUpper GI bleed Download CPSolvers App here RLRCPSOLVERS Click here to view the weekly ep ...  Show more

Recommended Episodes

S2 Episode 2: Is It Lupus Nephritis? A Path to Diagnosis and Treatment
Medscape InDiscussion: Chronic Kidney Disease

Join experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.m ...  Show more

Episode 897: Adrenal Crisis
Emergency Medical Minute

Contributor: Ricky Dhaliwal MD

Educational Pearls:

<ul> <li dir="ltr" aria-level="1">

Primary adrenal insufficiency (most common risk factor for adrenal crises)

</li> <ul> <li ...  Show more

364. Case Report: A Drug’s Adverse Effect Unleashes the Wolf – Beth Israel Deaconess Medical Center
Cardionerds: A Cardiology Podcast

CardioNerds join Dr. Inbar Raber and Dr. Susan Mcilvaine from the Beth Israel Deaconess Medical Center for a Fenway game. They discuss the following case: A 72-year-old man presents with two weeks of progressive dyspnea, orthopnea, nausea, vomiting, diarrhea, and right upper quad ...  Show more

365: CardioOncology: Cardiotoxicity of Novel Immunotherapies with Dr. Tomas Neilan
Cardionerds: A Cardiology Podcast

Immunotherapy is a type of novel cancer therapy that leverages the body’s own immune system to target cancer cells. In this episode, we focused on the most common type of immunotherapy: immune checkpoint inhibitors or ICIs. ICIs are monoclonal antibodies targeting immune “checkpo ...  Show more